Trastuzumab-induced Radiation Recall Dermatitis - First Reported Case

Clinical Oncology

Volumn 21, Issue 8, 2009, Pages 634-635

  Shrimali, R K ^a   McPhail, N J ^a   Correa, P D ^a   Fraser, J ^a   Rizwanullah, M ^a  

^a BEATSON WEST OF SCOTLAND CANCER CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANASTROZOLE; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; HYDROCORTISONE; PARACETAMOL; PROGESTERONE RECEPTOR; TRASTUZUMAB;

ADJUVANT THERAPY; AGED; AXILLARY LYMPH NODE; BREAST BIOPSY; BREAST CARCINOMA; BREAST MALFORMATION; CANCER GRADING; CANCER RADIOTHERAPY; CASE REPORT; ECHOGRAPHY; ERYTHEMA; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HISTOPATHOLOGY; HUMAN; LETTER; LYMPH NODE DISSECTION; MASTECTOMY; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; RADIATION DERMATITIS; RADIATION DOSE FRACTIONATION; TREATMENT OUTCOME; TUMOR VOLUME;

AGED; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; FEMALE; HUMANS; RADIATION INJURIES; RADIODERMATITIS;

EID: 69449104866     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2009.03.003     Document Type: Letter

References (6)

1. Common Toxicity Criteria, CTC Version 2.0. National Cancer Institute publications 9 (30 April 1999)
2. D'Angio G.J., Farber S., and Maddock C.L. Potentiation of X-ray effects of actinomycin D. Radiology 73 (1959) 175-177
3. Jeter M.D., Janne P.A., Brooks S., et al. Gemcitabine-induced radiation recall. Int J Radiat Oncol Biol Phys 53 (2002) 394-400
4. Camidge R., and Price A. Characterizing the phenomenon of radiation recall dermatitis. Radiother Oncol 59 (2001) 237-245
5. Azria D., Magne N., Zouhair A., et al. Radiation recall: a well recognized but neglected phenomenon. Cancer Treat Rev 31 (2005) 555-570
6. Camidge D.R., and Kunkler I.H. Docetaxel-induced radiation recall dermatitis and successful rechallenge without recurrence. Clin Oncol 12 (2000) 272-273